Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 6/2016

01.12.2016 | Research Article

Knowledge and pharmacological management of Alzheimer’s disease by managing community pharmacists: a nationwide study

verfasst von: Natalie Zerafa, Charles Scerri

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Background Managing community pharmacists can play a leading role in supporting community dwelling individuals with Alzheimer’s disease and their caregivers. Objective The main purpose of this study was to assess knowledge of managing community pharmacists towards Alzheimer’s disease and its pharmacological management. Setting Community pharmacies in the Maltese islands. Method A nationwide survey was conducted with full-time managing community pharmacists in possession of a tertiary education degree in pharmacy studies. The level of knowledge was investigated using the Alzheimer’s Disease Knowledge Scale and the Alzheimer’s Disease Pharmacotherapy Measure. Participants were also asked to rate a number of statements related to disease management. Results Maltese managing community pharmacists (57 % response rate) had inadequate knowledge on risk factors, caregiving issues and pharmacological management of Alzheimer’s disease. Age and number of years working in a community pharmacy setting were found to be negatively correlated with increased knowledge. Conclusion The findings highlight the need of providing training and continued educational support to managing community pharmacists in order to provide quality advice to individuals with dementia and their caregivers in the community.
Literatur
1.
Zurück zum Zitat Hofman A, Ott A, Breteler MMB, Bots ML, Slooter AJ, van Harskamp F, et al. Atherosclerosis, apolipoprotein E and prevalence of dementia and Alzheimer’s disease in the Rotterdam study. Lancet. 1997;349:151–4.CrossRefPubMed Hofman A, Ott A, Breteler MMB, Bots ML, Slooter AJ, van Harskamp F, et al. Atherosclerosis, apolipoprotein E and prevalence of dementia and Alzheimer’s disease in the Rotterdam study. Lancet. 1997;349:151–4.CrossRefPubMed
2.
Zurück zum Zitat McGuffey EC. Alzheimer’s disease: an overview for the pharmacist. J Am Pharm Assoc (Wash). 1997;NS37:347–52.CrossRef McGuffey EC. Alzheimer’s disease: an overview for the pharmacist. J Am Pharm Assoc (Wash). 1997;NS37:347–52.CrossRef
4.
Zurück zum Zitat Cummings JL, Mackell J, Kaufer D. Behavioral effects of current Alzheimer’s disease treatments: a descriptive review. Alzheimer’s Dement. 2008;4:49–60.CrossRef Cummings JL, Mackell J, Kaufer D. Behavioral effects of current Alzheimer’s disease treatments: a descriptive review. Alzheimer’s Dement. 2008;4:49–60.CrossRef
5.
Zurück zum Zitat Scerri A, Scerri C. Dementia in Malta: new prevalence estimates and projected trends. Malta Med J. 2012;24:21–4. Scerri A, Scerri C. Dementia in Malta: new prevalence estimates and projected trends. Malta Med J. 2012;24:21–4.
6.
Zurück zum Zitat Scerri C. Empowering change: a national strategy for dementia in the Maltese Islands. Valletta: Parliamentary Secretariat for the Rights of Persons with Disability and Active Ageing; 2015. Scerri C. Empowering change: a national strategy for dementia in the Maltese Islands. Valletta: Parliamentary Secretariat for the Rights of Persons with Disability and Active Ageing; 2015.
7.
Zurück zum Zitat Skelton J. White paper on expanding the role of pharmacists in caring for individuals with Alzheimer’s disease. J Am Pharm Assoc. 2008;48:715–21.CrossRef Skelton J. White paper on expanding the role of pharmacists in caring for individuals with Alzheimer’s disease. J Am Pharm Assoc. 2008;48:715–21.CrossRef
8.
Zurück zum Zitat Galt KA, Fuji KT, Faber J. Patient safety problem identification and solution sharing among rural community pharmacists. J Am Pharm Assoc. 2013;53:584–94.CrossRef Galt KA, Fuji KT, Faber J. Patient safety problem identification and solution sharing among rural community pharmacists. J Am Pharm Assoc. 2013;53:584–94.CrossRef
9.
Zurück zum Zitat Rickles NM, Skelton JB, Davis J, Hopson J. Cognitive memory screening and referral program in community pharmacies in the United States. Int J Clin Pharm. 2014;36:360–7.CrossRefPubMed Rickles NM, Skelton JB, Davis J, Hopson J. Cognitive memory screening and referral program in community pharmacies in the United States. Int J Clin Pharm. 2014;36:360–7.CrossRefPubMed
11.
Zurück zum Zitat Caruana-Pulpan O, Scerri C. Practices in diagnosis, disclosure and pharmacotherapeutic management of dementia by general practitioners—a national survey. Aging Ment Health. 2014;18:179–86.CrossRefPubMed Caruana-Pulpan O, Scerri C. Practices in diagnosis, disclosure and pharmacotherapeutic management of dementia by general practitioners—a national survey. Aging Ment Health. 2014;18:179–86.CrossRefPubMed
12.
Zurück zum Zitat Cerejeira J, Lagarto L, Mukaetova-Ladinska EB. Behavioral and psychological symptoms of dementia. Front Neurol. 2012;7:73. Cerejeira J, Lagarto L, Mukaetova-Ladinska EB. Behavioral and psychological symptoms of dementia. Front Neurol. 2012;7:73.
14.
Zurück zum Zitat Carpenter BD, Balsis S, Otilingam PG, Hanson PK, Gatz M. The Alzheimer’s Disease Knowledge Scale: development and psychometric properties. Gerontologist. 2009;49:236–47.CrossRefPubMedPubMedCentral Carpenter BD, Balsis S, Otilingam PG, Hanson PK, Gatz M. The Alzheimer’s Disease Knowledge Scale: development and psychometric properties. Gerontologist. 2009;49:236–47.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Polit DF, Beck CT. Essentials of nursing research: appraising evidence for nursing practice. 7th ed. Philadelphia: Lippincott; 2010. Polit DF, Beck CT. Essentials of nursing research: appraising evidence for nursing practice. 7th ed. Philadelphia: Lippincott; 2010.
16.
Zurück zum Zitat Scerri A, Scerri C. Nursing students’ knowledge and attitudes towards dementia—a questionnaire survey. Nurse Educ Today. 2013;33:962–8.CrossRefPubMed Scerri A, Scerri C. Nursing students’ knowledge and attitudes towards dementia—a questionnaire survey. Nurse Educ Today. 2013;33:962–8.CrossRefPubMed
17.
Zurück zum Zitat Nordhus IH, Sivertsen B, Pallesen S. Knowledge about Alzheimer’s disease among Norwegian psychologists. Aging Ment Health. 2012;16:521–8.CrossRefPubMed Nordhus IH, Sivertsen B, Pallesen S. Knowledge about Alzheimer’s disease among Norwegian psychologists. Aging Ment Health. 2012;16:521–8.CrossRefPubMed
18.
Zurück zum Zitat Smyth W, Fielding E, Beattie E, Gardner A, Moyle W, Franklin S, et al. A survey-based study of knowledge of Alzheimer’s disease among health care staff. BMC Geriatr. 2013;13:2.CrossRefPubMedPubMedCentral Smyth W, Fielding E, Beattie E, Gardner A, Moyle W, Franklin S, et al. A survey-based study of knowledge of Alzheimer’s disease among health care staff. BMC Geriatr. 2013;13:2.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Koch T, Iliffe S. EVIDEM-ED project. Rapid appraisal of barriers to the diagnosis and management of patients with dementia in primary care: a systemic review. BMC Fam Pract. 2010;11:52.CrossRefPubMedPubMedCentral Koch T, Iliffe S. EVIDEM-ED project. Rapid appraisal of barriers to the diagnosis and management of patients with dementia in primary care: a systemic review. BMC Fam Pract. 2010;11:52.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat de la Torre JC. Basics of Alzheimer’s disease prevention. J Alzheimers Dis. 2010;20:687–8.PubMed de la Torre JC. Basics of Alzheimer’s disease prevention. J Alzheimers Dis. 2010;20:687–8.PubMed
21.
Zurück zum Zitat Herrmann N, Chau SA, Kircanski I, Lanctot KIL. Current and emerging drug treatment options for Alzheimer’s disease: a systemic review. Drugs. 2011;71:2031–65.CrossRefPubMed Herrmann N, Chau SA, Kircanski I, Lanctot KIL. Current and emerging drug treatment options for Alzheimer’s disease: a systemic review. Drugs. 2011;71:2031–65.CrossRefPubMed
22.
Zurück zum Zitat Stella F, Radanovic M, Canineu PR, de Paula VJ, Forlenza OV. Anti-dementia medications: current prescriptions in clinical practice and new agents in progress. Ther Adv Drug Saf. 2015;6:151–65.CrossRefPubMedPubMedCentral Stella F, Radanovic M, Canineu PR, de Paula VJ, Forlenza OV. Anti-dementia medications: current prescriptions in clinical practice and new agents in progress. Ther Adv Drug Saf. 2015;6:151–65.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Mort JR, Gaspar P, Pulscher S, Laird L. Management of demented patients within the community: techniques utilized and the impact of education. Clin Gerontol. 1993;13:23–45.CrossRef Mort JR, Gaspar P, Pulscher S, Laird L. Management of demented patients within the community: techniques utilized and the impact of education. Clin Gerontol. 1993;13:23–45.CrossRef
26.
Zurück zum Zitat Rojas-Fernandez CH, Eng M, Allie ND. Pharmacologic management by clinical pharmacists of behavioural and psychological symptoms of dementia in nursing home residents: results from a pilot study. Pharmacotherapy. 2003;23:217–21.CrossRefPubMed Rojas-Fernandez CH, Eng M, Allie ND. Pharmacologic management by clinical pharmacists of behavioural and psychological symptoms of dementia in nursing home residents: results from a pilot study. Pharmacotherapy. 2003;23:217–21.CrossRefPubMed
27.
Zurück zum Zitat Schmidt I, Claesson CB, Westerholm B, Nilsson LG, Svarstad BL. The impact of regular multidisciplinary team interventions on psychotropic prescribing in Swedish nursing homes. J Am Geriatr Soc. 1998;46:77–82.CrossRefPubMed Schmidt I, Claesson CB, Westerholm B, Nilsson LG, Svarstad BL. The impact of regular multidisciplinary team interventions on psychotropic prescribing in Swedish nursing homes. J Am Geriatr Soc. 1998;46:77–82.CrossRefPubMed
28.
Zurück zum Zitat Westbury J, Jackson S, Gee P, Peterson G. An effective approach to decrease antipsychotic and benzodiazepine use in nursing homes: the RedUSe project. Int Psychogeriatr. 2010;22:26–36.CrossRefPubMed Westbury J, Jackson S, Gee P, Peterson G. An effective approach to decrease antipsychotic and benzodiazepine use in nursing homes: the RedUSe project. Int Psychogeriatr. 2010;22:26–36.CrossRefPubMed
Metadaten
Titel
Knowledge and pharmacological management of Alzheimer’s disease by managing community pharmacists: a nationwide study
verfasst von
Natalie Zerafa
Charles Scerri
Publikationsdatum
01.12.2016
Verlag
Springer International Publishing
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 6/2016
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-016-0380-8

Weitere Artikel der Ausgabe 6/2016

International Journal of Clinical Pharmacy 6/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.